Drittlinientherapie mit Quinacrin und Metronidazol bei refraktärer Giardiasis

Friederike Hunstig; Johannes Jochum; Egbert Tannich; Benno Kreuels

doi:10.1055/a-1261-1417

Flugmedizin · Tropenmedizin · Reisemedizin - FTR, Table of Contents

Flugmedizin · Tropenmedizin · Reisemedizin - FTR 2020; 27(05): 216-218
DOI: 10.1055/a-1261-1417

Kasuistik

Georg Thieme Verlag KG Stuttgart · New York

Drittlinientherapie mit Quinacrin und Metronidazol bei refraktärer Giardiasis

Third-line treatment with quinacrine and metronidazole in refractory giardiasis

Friederike Hunstig

¹Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and I. Department of Medicine University Medical Center Hamburg-Eppendorf, Hamburg

,

Johannes Jochum

¹Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and I. Department of Medicine University Medical Center Hamburg-Eppendorf, Hamburg

,

Egbert Tannich

²National Reference Centre for Tropical Pathogens, Bernhard Nocht Institute for Tropical Medicine, Hamburg

,

Benno Kreuels

¹Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and I. Department of Medicine University Medical Center Hamburg-Eppendorf, Hamburg

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Robert Koch-Institut. Reiseassoziierte Krankheiten. 2018 Im Internet www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2019/Ausgaben/48_19.pdf
2 Neumayr A. Antiparasitic Treatment Recommendations. Hamburg: tredition GmbH; 2018
3 Nabarro LE, Lever RA, Armstrong M. et al Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013. Clin Microbiol Infect 2015; 21: 791-796
4 Nash TE, Ohl CA, Thomas E. et al Treatment of patients with refractory giardiasis. Clin Infect Dis 2001; 33: 22-28
5 Lalle M, Hanevik K. Treatment-refractory giardiasis: challenges and solutions. Infect Drug Resist 2018; 11: 1921-1933